Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Biopharmaceutical Statistics
|
May 20, 2014
A flexible Bayesian approach for modeling monotonic dose-response relationships in drug development trials
David Ohlssen, Amy Racine
Statistics in Medicine
|
July 30, 2021
Using knockoffs for controlled predictive biomarker identification
Konstantinos Sechidis, Matthias Kormaksson, David Ohlssen
Pharmaceutical Statistics
|
June 18, 2015
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trial
Francois Mercier, Bjoern Bornkamp, David Ohlssen, et al.
Pharmaceutical Statistics
|
December 10, 2016
Model averaging for treatment effect estimation in subgroups
Björn Bornkamp, David Ohlssen, Baldur P Magnusson, et al.
Statistics in Medicine
|
April 27, 2013
Bayesian modeling and inference for clinical trials with partial retrieved data following dropout
Qingxia Chen, Ming-Hui Chen, David Ohlssen, et al.
Pharmaceutical Statistics
|
September 17, 2013
A practical guide to Bayesian group sequential designs
Thomas Gsponer, Florian Gerber, Björn Bornkamp, et al.
Clinical Pharmacology and Therapeutics
|
February 29, 2024
All that Glitters Is not Gold: Type-I Error Controlled Variable Selection from Clinical Trial Data
Manuela R Zimmermann, Mark Baillie, Matthias Kormaksson, et al.
Statistics in Medicine
|
April 26, 2021
Sequential knockoffs for continuous and categorical predictors: With application to a large psoriatic arthritis clinical trial pool
Matthias Kormaksson, Luke J Kelly, Xuan Zhu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 28, 2011
Safety of formoterol in adults and children with asthma: a meta-analysis
James Kemp, Linda Armstrong, Ying Wan, et al.
Pharmaceutical Statistics
|
September 13, 2013
The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group
Fanni Natanegara, Beat Neuenschwander, John W Seaman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Biopharmaceutical Statistics
|
May 20, 2014
A flexible Bayesian approach for modeling monotonic dose-response relationships in drug development trials
David Ohlssen, Amy Racine
Statistics in Medicine
|
July 30, 2021
Using knockoffs for controlled predictive biomarker identification
Konstantinos Sechidis, Matthias Kormaksson, David Ohlssen
Pharmaceutical Statistics
|
June 18, 2015
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trial
Francois Mercier, Bjoern Bornkamp, David Ohlssen, et al.
Pharmaceutical Statistics
|
December 10, 2016
Model averaging for treatment effect estimation in subgroups
Björn Bornkamp, David Ohlssen, Baldur P Magnusson, et al.
Statistics in Medicine
|
April 27, 2013
Bayesian modeling and inference for clinical trials with partial retrieved data following dropout
Qingxia Chen, Ming-Hui Chen, David Ohlssen, et al.
Pharmaceutical Statistics
|
September 17, 2013
A practical guide to Bayesian group sequential designs
Thomas Gsponer, Florian Gerber, Björn Bornkamp, et al.
Clinical Pharmacology and Therapeutics
|
February 29, 2024
All that Glitters Is not Gold: Type-I Error Controlled Variable Selection from Clinical Trial Data
Manuela R Zimmermann, Mark Baillie, Matthias Kormaksson, et al.
Statistics in Medicine
|
April 26, 2021
Sequential knockoffs for continuous and categorical predictors: With application to a large psoriatic arthritis clinical trial pool
Matthias Kormaksson, Luke J Kelly, Xuan Zhu, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
June 28, 2011
Safety of formoterol in adults and children with asthma: a meta-analysis
James Kemp, Linda Armstrong, Ying Wan, et al.
Pharmaceutical Statistics
|
September 13, 2013
The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group
Fanni Natanegara, Beat Neuenschwander, John W Seaman, et al.
Page
of 2